IL2 and neoplasm: In contrast to lymphokine-activated killer (LAK) cells, which are cytotoxic effector T-cells stimulated predominantly in response to high concentration of interleukin-2 (IL-2), CIK cells exhibit enhanced tumor cell lytic activity [20], [21], higher proliferation rate [22], and relatively lower toxicity [23].